晚期CKD伴血管钙化患者的次级钙蛋白颗粒流体力学半径较大
该研究采用动态光散射法检测CKD 4-5期患者血清中次级钙蛋白颗粒(CPP2)的流体力学半径(Rh)及转化速度(T50),发现伴血管钙化者CPP2的Rh显著大于无钙化者及健康志愿者,且Rh与血管钙化独立相关,而T50无此关联。
要点
- CKD 4-5期伴血管钙化者CPP2的Rh显著大于无钙化者和健康志愿者。
- CPP2的Rh每增加10 nm,血管钙化风险增加9%(OR 1.09,95%CI 1.03-1.16)。
- T50在伴与不伴血管钙化的CKD患者间无差异,但均低于健康志愿者。
核心结论
- 在CKD 4-5期患者中,CPP2的流体力学半径(Rh)而非T50,与血管钙化独立相关。
研究设计与样本
- 研究纳入45例CKD 4-5期患者(22例无血管钙化,23例有血管钙化)和17名健康志愿者,采用基于动态光散射的高通量微板法检测CPP1向CPP2转化、CPP1和CPP2的Rh、T50及CPP2聚集。
主要发现
- 伴血管钙化的CKD患者CPP2累积Rh为370 nm(IQR 272-566),大于无血管钙化者的212 nm(IQR 169-315)和健康志愿者的168 nm(IQR 145-352),P均<0.01。
- 伴血管钙化的CKD患者中CPP2聚集比例为70%,高于无血管钙化者的36%。
- 调整年龄、糖尿病、血钙和血磷后,CPP2的Rh每增加10 nm,血管钙化风险增加9%(OR 1.09,95%CI 1.03-1.16,P=0.005)。
- CPP2大小预测血管钙化的ROC曲线下面积为0.75(95%CI 0.60-0.90)。
- 伴与不伴血管钙化的CKD患者T50相似,但两组均低于健康志愿者。
关键数值与推荐
- 血管钙化定义为Kauppila评分>6或Adragao评分≥3。
临床怎么用
- CPP2的Rh可作为CKD 4-5期患者血管钙化的潜在生物标志物,但需进一步验证。
局限性
- 样本量较小(45例CKD患者和17名健康志愿者),为横断面研究,无法确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The size of secondary calciprotein particles (CPP2) and the speed of transformation (T50) from primary calciprotein particles (CPP1) to CPP2 in serum may be associated with vascular calcification (VC) in patients with chronic kidney disease (CKD). METHODS: We developed a high throughput, microplate-based assay using dynamic light scattering (DLS) to measure the transformation of CPP1 to CPP2, hydrodynamic radius (Rh) of CPP1 and CPP2, T50 and aggregation of CPP2. We used this DLS assay to test the hypothesis that a large Rh of CPP2 and/or a fast T50 are associated with VC in 45 participants with CKD Stages 4-5 (22 without VC and 23 with VC) and 17 healthy volunteers (HV). VC was defined as a Kauppila score >6 or an Adragao score ≥3. RESULTS: CKD participants with VC had larger cumulants Rh of CPP2 {370 nm [interquartile range (IQR) 272-566]} compared with CKD participants without VC [212 nm (IQR 169-315)] and compared with HV [168 nm (IQR 145-352), P < 0.01 for each]. More CPP2 were in aggregates in CKD participants with VC than those without VC (70% versus 36%). The odds of having VC increased by 9% with every 10 nm increase in the Rh of CPP2, after adjusting for age, diabetes, serum calcium and phosphate [odds ratio 1.09, 95% confidence interval (CI) 1.03, 1.16, P = 0.005]. The area under the receiver operating characteristic curve for VC of CPP2 size was 0.75 (95% CI 0.60, 0.90). T50 was similar in CKD participants with and without VC, although both groups had a lower T50 than HV. CONCLUSIONS: Rh of CPP2, but not T50, is independently associated with VC in patients with CKD Stages 4-5.
引用
- Chen W, Anokhina V, Dieudonne G, et al. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles. Nephrol Dial Transplant. 2019. PMID: 29788425. doi:10.1093/ndt/gfy117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。